Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy – a retrospective study including 32 patients

Overview of attention for article published in BMC Cancer, August 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 4,327 followers.

@DrChowdharyMD @santam @CancerConnector @ShaunaRadOnc @CShahMD @SchaubMD @jryckman3 -Why not 25/5? Or 24/3? I think dec fractions offers more value than dec dose (happy to debate) -I want someone to be very bold and trial total neoadjuvant therapy here 🤯

Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline thera… https://t.co/NdtGL51Vri

Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline ther… https://t.co/8foEKehE8m

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.